Highlights

BRI Receives Second 7-Year Award from the NIH to Lead the ITN

This grant supports the work of the ITN in cutting-edge clinical trials that, in conjunction with laboratory studies of immunological responses, are designed to uncover and target immune system checkpoints that have the ability to reverse autoimmune diseases and allergies and facilitate organ transplantation. More

Resources